Search clinical trials for: Muscarinic Antagonists

Total 32913 results

Chiesi Farmaceutici S.p.A.

Completed

Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and Glycopyrrolate

Pulmonary Disease, Chronic Obstructive

United Kingdom
Journey Medical Corporation

Completed

A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis

Hyperhidrosis

United States
Stéphane Bolduc
Pfizer

Completed

Fesoterodine and Oxybutynin XL for Overactive Bladder Syndrome in Children (FOXY)

Overactive Bladder
SK Chemicals Co., Ltd.

Completed

Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB

Overactive Bladder

Korea, Republic of
Mount Sinai Hospital, Canada
The Physicians' Services Incorporated Foundation; Baycrest

Terminated

Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older (DEFEND)

Nocturia

Canada
Novartis Pharmaceuticals

Completed

Long Term Safety Study of NVA237 vs QAB149 in COPD Patients

Chronic Obstructive Pulmonary Disease (COPD)

United States
Dr .S.B.PATANKAR

Completed

Study of Herbmed Plus in Ureteral Stent Discomfort

Ureteral Stent Discomfort

India
Watson Pharmaceuticals

Completed

Effects of Oxybutynin Topical Gel on Gastric Emptying

Healthy

United States
University Medicine Greifswald
RIEMSER Arzneimittel GmbH

Completed

Bioavailability of Vagantin® Coated Tablets Relative to an Oral Methantheline Bromide Solution

Neurogenic Bladder

Germany
Federal University of São Paulo

Completed

A Study to Compare Oxybutynin to a Placebo in Women and the Effect on Plantar Hyperhidrosis

Hyperhidrosis
Samsung Medical Center

Completed

Urinary Urgency Outcomes Following Propiverine Treatment for an Overactive Bladder

Overactive Bladder

Korea, Republic of
Mansoura University
Ahmed Mohamed Elshal

Completed

Efficacy of Li-SWT on Persistent Storage Symptoms After Transurethral Surgery for BPO

Overactive Bladder | Urinary Incontinence, Urge | Urgency-frequency Syndrome | Post Prostatectomy

Egypt
Pfizer

Completed

Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity.

Urinary Bladder, Neurogenic

Japan
Taris Biomedical LLC

Completed

Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder

Idiopathic Overactive Bladder With Urinary Incontinence

United States
Allergan

Completed

Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial

Overactive Bladder | Pharmacokinetics | Elderly

United States
APOGEPHA Arzneimittel GmbH

Completed

Propiverine in Children Suffering From Non-Neurogenic Overactive Bladder and Urinary Incontinence

Overactive Bladder | Urinary Incontinence | Children
Novartis Pharmaceuticals

Recruiting

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma

Asthma

Spain, Hungary, United Kingdom, South Africa, Colombia, Bulgaria, Poland, Guatemala
Becky Clarkson
National Institute on Aging (NIA)

Recruiting

Investigation of Brain Mechanisms Involved in Urgency Urinary Incontinence

Urgency Urinary Incontinence

United States
Far Eastern Memorial Hospital

Completed

Efficacy of Biofeedback PFMT and Medication in Women With Overactive Bladder (PFMT)

Overactive Bladder

Taiwan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Effects Of Detrol LA On Memory And Cognition In Elderly Population

Cognition | Memory

United States
Merck Sharp & Dohme LLC

Completed

A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008)

Urinary Bladder, Overactive
Hartford Hospital
Astellas Pharma Inc

Terminated

Clinical Trial of Solifenacin Versus Placebo Plus Pessary for Women With Vaginal Prolapse (PESSARY)

Pelvic Organ Prolapse

United States
Novartis

Completed

Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over

Healthy Volunteers

United States
Siami, Paul F., M.D.
GlaxoSmithKline; Pfizer

Completed

Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS) (LUTS)

Benign Prostatic Hyperplasia (BPH)

United States
Mansoura University

Recruiting

Efficacy of Mirabegron Versus Tamsulosin Versus Solifenacin for Treatment of Ureteral Stents-Related Symptoms

Ureteral Stent | Stent Related Symptoms

Egypt
Cantonal Hospital, Frauenfeld
Astellas Pharma Inc

Completed

Therapy of the Overactive Bladder Syndrome (TOBS)

Overactive Bladder

Switzerland
Soroka University Medical Center

Unknown

Comparison of Refraction Measurments in Children Under General Anesthesia, With and Without Cycloplegic Drops

General Anesthesia

Israel
Xuanwu Hospital, Beijing

Not yet recruiting

Efficacy Comparison Between Different Management Strategies for Consistent OAB in Patients With SVMs After Surgery

Overactive Bladder | Spinal Vascular Disorder Nos
Islamic Hospital, Jordan
Jordan University of Science and Technology; Yarmouk University

Recruiting

Cycloplegic Refraction in Pediatric Patients With Esotropia

Refractive Errors | Vision Disorders | Esotropia | Cycloplegia

Jordan, Qatar
URAL Telekomunikasyon San. Trade Inc.
Akdeniz University

Recruiting

Assessment of EyeCheckup as an Automated Diabetic Retinopathy Screening Tool

Diabetic Retinopathy | Diabetic Macular Edema | Diabetic Eye Problems

Turkey
Far Eastern Memorial Hospital

Recruiting

Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus Solifenacin

Overactive Bladder Syndrome

Taiwan
Dong-A ST Co., Ltd.

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder

Overactive Bladder

Korea, Republic of
The Cleveland Clinic

Completed

Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular

Anesthesia | Neuromuscular Blockade

United States
Urovant Sciences GmbH

Completed

A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) (Empowur)

Overactive Bladder

United States, Latvia, Hungary, Canada, Lithuania, Poland
Astellas Pharma Inc

Completed

Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis (SONIC)

Multiple Sclerosis | Spinal Cord Diseases | Neurogenic Bladder

Australia, France, Belgium, Germany, Netherlands, Italy, Spain, United Kingdom, Hungary, Czechia, Russian Federation
US Department of Veterans Affairs

Completed

Behavioral Treatment of Overactive Bladder in Men (MOTIVE)

Overactive Bladder

United States
Novartis

Completed

Safety and Tolerability of QVA149 (Indacaterol/Glycopyrrolate) Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

France, Germany, Belgium, Spain, Turkey, Italy, Canada, Australia
Novartis

Completed

Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

United States, Spain, Turkey, France, Netherlands, Germany
Novartis

Completed

A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo (GLOW 1)

Chronic Obstructive Pulmonary Disease

Russian Federation, Singapore, United States, Canada, Korea, Republic of, Japan, Spain, Turkey, Romania, Australia, Netherlands
Astellas Pharma Inc
Astellas Pharma Canada, Inc.

Completed

Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR) (VECTOR)

Overactive Bladder

Canada
Boston University
Centers for Disease Control and Prevention

Completed

Effects of Transdermal Scopolamine on Occupational Performance

Motion Sickness

Sweden
Mayo Clinic

Recruiting

Neostigmine and Glycopyrrolate for the Treatment of Headache After Dural Puncture

Post-Dural Puncture Headache

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Active, not recruiting

Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer

Prostate Carcinoma

United States
University of Kansas Medical Center

Completed

Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery

Burns

United States
Islamic Hospital, Jordan

Completed

Cycloplegic Refraction Among Children

Cycloplegia

Jordan
Swiss Federal Institute of Technology
University of Stellenbosch

Completed

Stable Iron Isotope Method in HIV+ and HIV- Children

Iron-deficiency

South Africa
Taris Biomedical LLC

Completed

Safety and Tolerability of TAR-302-5018 in Subjects With Neurogenic Detrusor Overactivity Resulting From Spinal Cord Injury

Neurogenic Detrusor Overactivity

United States
CHU de Reims

Unknown

Evaluation of a Protocol of Pupil Dilation Before Laser-assisted Cataract Surgery (MYFLACS)

Cataract Surgery

France
US Department of Veterans Affairs

Completed

Enhancing Conservative Treatment for Urge Incontinence (COMBO)

Urinary Incontinence

United States
Alza Corporation, DE, USA

Completed

A Study Comparing the Efficacy and Safety of OROS® Oxybutynin to That of Ditropan® (Immediate-release Oxybutynin) for the Treatment of Patients With Urge or Mixed Urinary Incontinence.

Urge Incontinence

Search clinical trials for: Muscarinic Antagonists

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations